AKER News and Press, Akers Biosciences Inc. From 04/22/20

Source: marketbeat In March, the obscure biotech company Akers Biosciences (AKER) became known to a larger number of investors on the news it had entered into a licensing deal with Premas Biotech to work together on developing a vaccine to treat COVID-19, including Akers' expertise in ...

Gainers:  Independence Contract Drilling (NYSE: ICD ) +204% . More news on: Independence Contract Drilling, Inc., Pluristem Therapeutics Inc., Nautilus, Inc., Stocks on the move, , Read more ...

Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its collaboration with Premas Biotech has successfully completed a second milestone, the...

April 8, 2020 Palm Beach, FL – April 8, 2020 – The search for vaccines and treatments for the global health crises is now focusing on medicines that are presently approved for other ailments. A recent article in the LA Times discussed this issue saying that when ...

Akers Biosciences ( AKER +27.1% ) inks agreements with several institutional and accredited investors for the sale of 766,667 common shares at $6.00 per share. Gross proceeds should be $4.6M. More news on: Akers Biosciences, Inc., Healthcare stocks news, , Stocks on the move, Read ...

Thorofare, New Jersey, April 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has entered into definitive agreements with several institutional and accredited inve...

Sasol (NYSE: SSL ) +47% . More news on: Sasol Limited, Cherry Hill Mortgage Investment Corporation, Can-Fite BioPharma Ltd., Stocks on the move, , Read more ...

Gainers:  Immunomedics (NASDAQ: IMMU )  +90% . More news on: Immunomedics, Inc., Akers Biosciences, Inc., Exantas Capital Corp., Stocks on the move, , Read more ...

Thinly traded nano cap Akers Biosciences ( AKER +62.4% ) rallies on a healthy 25x surge in volume in reaction to the advancement of its COVID-19 vaccine candidate. More news on: Akers Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Successfully obtained clones for all three selected Coronavirus Antigens Thorofare, New Jersey, April 06, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its coll...